Eptifibatide Aftpharm

Eptifibatide is an intravenous medication used to prevent blood clots. It belongs to a class of drugs known as glycoprotein IIb/IIIa inhibitors, often used in cardiac procedures.

Eptifibatide is primarily used to prevent blood clots in patients undergoing certain heart procedures. It works by inhibiting platelet aggregation, which is crucial in managing acute coronary syndromes. This medication is often administered in hospital settings for short-term use.

Common effects of Eptifibatide may include bleeding at the injection site, bruising, and low blood pressure. Some patients might experience nausea or dizziness. These effects are generally monitored by healthcare professionals during administration.

Eptifibatide should be used with caution in patients with a history of bleeding disorders or recent surgery. It is important to inform healthcare providers about any allergies or current medications before starting treatment. Regular monitoring is essential during therapy.

Eptifibatide may interact with other blood-thinning medications, increasing the risk of bleeding. It is important to avoid alcohol and certain pain relievers while using this medication. Always consult a healthcare provider before combining treatments.